{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:44:08Z","timestamp":1788320648020,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","award":["01D42414"],"award-info":[{"award-number":["01D42414"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00216-018-0866-4","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T05:36:44Z","timestamp":1516685804000},"page":"2331-2341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs"],"prefix":"10.1007","volume":"410","author":[{"given":"Sofie","family":"Velghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"866_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2015.04.008","volume":"75","author":"D Milosheska","year":"2015","unstructured":"Milosheska D, Grabnar I, Vovk T. Dried blood spots for monitoring and individualization of antiepileptic drug treatment. Eur J Pharm Sci. 2015;75:25\u201339.","journal-title":"Eur J Pharm Sci"},{"key":"866_CR2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cca.2014.06.002","volume":"436","author":"MD Krasowski","year":"2014","unstructured":"Krasowski MD, McMillin GA. Advances in anti-epileptic drug testing. Clin Chim Acta. 2014;436:224\u201336.","journal-title":"Clin Chim Acta"},{"key":"866_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2016.01.030","volume":"84","author":"S Velghe","year":"2016","unstructured":"Velghe S, Capiau S, Stove CP. Opening the toolbox of alternative sampling strategies in clinical routine: a key-role for (LC-)MS\/MS. Trac Trend Anal Chem. 2016;84:61\u201373.","journal-title":"Trac Trend Anal Chem"},{"key":"866_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-12-802025-8.00013-1","volume-title":"Clinical challenges in therapeutic drug monitoring","author":"S Capiau","year":"2016","unstructured":"Capiau S, Alffenaar J-W, Stove CP. Alternative sampling strategies for therapeutic drug monitoring. In: Clarke W, Dasgupta A, editors. Clinical challenges in therapeutic drug monitoring. Amsterdam: Elsevier; 2016. p. 279\u2013336."},{"key":"866_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2013.02.005","volume":"923-924","author":"NM Shah","year":"2013","unstructured":"Shah NM, Hawwa AF, Millership JS, Collier PS, McElnay JC. A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;923-924:65\u201373.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"8","key":"866_CR6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/bmc.2905","volume":"27","author":"TV Popov","year":"2013","unstructured":"Popov TV, Maricic LC, Prosen H, Voncina DB. Development and validation of dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2013;27(8):1054\u201361.","journal-title":"Biomed Chromatogr"},{"issue":"16","key":"866_CR7","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4155\/bio.15.99","volume":"7","author":"C Linder","year":"2015","unstructured":"Linder C, Andersson M, Wide K, Beck O, Pohanka A. A LC-MS\/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS. Bioanalysis. 2015;7(16):2031\u20139.","journal-title":"Bioanalysis"},{"key":"866_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2014.11.007","volume":"440","author":"F Villanelli","year":"2015","unstructured":"Villanelli F, Giocaliere E, Malvagia S, Rosati A, Forni G, Funghini S, et al. Dried blood spot assay for the quantification of phenytoin using liquid chromatography-mass spectrometry. Clin Chim Acta. 2015;440:31\u20135.","journal-title":"Clin Chim Acta"},{"key":"866_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpba.2015.02.045","volume":"109","author":"E Shokry","year":"2015","unstructured":"Shokry E, Villanelli F, Malvagia S, Rosati A, Forni G, Funghini S, et al. Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry. J Pharm Biomed Anal. 2015;109:164\u201370.","journal-title":"J Pharm Biomed Anal"},{"issue":"11\u201312","key":"866_CR10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1365\/s10337-010-1569-y","volume":"71","author":"S AbuRuz","year":"2010","unstructured":"AbuRuz S, Al-Ghazawi M, Al-Hiari Y. A simple dried blood spot assay for therapeutic drug monitoring of lamotrigine. Chromatographia. 2010;71(11\u201312):1093\u20139.","journal-title":"Chromatographia"},{"issue":"12","key":"866_CR11","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/j.1528-1167.2009.02204.x","volume":"50","author":"G Marca la","year":"2009","unstructured":"la Marca G, Malvagia S, Filippi L, Luceri F, Moneti G, Guerrini R. A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry. Epilepsia. 2009;50(12):2658\u201362.","journal-title":"Epilepsia"},{"issue":"5","key":"866_CR12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jpba.2008.09.025","volume":"48","author":"G Marca la","year":"2008","unstructured":"la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, et al. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal. 2008;48(5):1392\u20136.","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"866_CR13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","volume":"53","author":"AJ Wilhelm","year":"2014","unstructured":"Wilhelm AJ, den Burger JC, Swart EL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin Pharmacokinet. 2014;53(11):961\u201373.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"866_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.11.337","volume":"4","author":"L Fan","year":"2012","unstructured":"Fan L, Lee JA. Managing the effect of hematocrit on DBS analysis in a regulated environment. Bioanalysis. 2012;4(4):345\u20137.","journal-title":"Bioanalysis"},{"issue":"14","key":"866_CR15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4155\/bio.14.151","volume":"6","author":"PM Kesel De","year":"2014","unstructured":"De Kesel PM, Capiau S, Lambert WE, Stove CP. Current strategies for coping with the hematocrit problem in dried blood spot analysis. Bioanalysis. 2014;6(14):1871\u20134.","journal-title":"Bioanalysis"},{"issue":"19","key":"866_CR16","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/rcm.5182","volume":"25","author":"N Youhnovski","year":"2011","unstructured":"Youhnovski N, Bergeron A, Furtado M, Garofolo F. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact. Rapid Commun Mass Spectrom. 2011;25(19):2951\u20138.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"26","key":"866_CR17","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1007\/s00216-014-8114-z","volume":"406","author":"PM Kesel De","year":"2014","unstructured":"De Kesel PM, Capiau S, Stove VV, Lambert WE, Stove CP. Potassium-based algorithm allows correction for the hematocrit bias in quantitative analysis of caffeine and its major metabolite in dried blood spots. Anal Bioanal Chem. 2014;406(26):6749\u201355.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"866_CR18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00216-014-8291-9","volume":"407","author":"JC Burger den","year":"2015","unstructured":"den Burger JC, Wilhelm AJ, Chahbouni AC, Vos RM, Sinjewel A, Swart EL. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement. Anal Bioanal Chem. 2015;407(2):621\u20137.","journal-title":"Anal Bioanal Chem"},{"issue":"10","key":"866_CR19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/rcm.6212","volume":"26","author":"Y Li","year":"2012","unstructured":"Li Y, Henion J, Abbott R, Wang P. The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood. Rapid Commun Mass Spectrom. 2012;26(10):1208\u201312.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"20","key":"866_CR20","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4155\/bio.11.219","volume":"3","author":"F Li","year":"2011","unstructured":"Li F, Zulkoski J, Fast D, Michael S. Perforated dried blood spots: a novel format for accurate microsampling. Bioanalysis. 2011;3(20):2321\u201333.","journal-title":"Bioanalysis"},{"issue":"16","key":"866_CR21","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4155\/bio.12.175","volume":"4","author":"RJ Meesters","year":"2012","unstructured":"Meesters RJ, Zhang J, van Huizen NA, Hooff GP, Gruters RA, Luider TM. Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis. Bioanalysis. 2012;4(16):2027\u201335.","journal-title":"Bioanalysis"},{"issue":"4","key":"866_CR22","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ac503931g","volume":"87","author":"LA Leuthold","year":"2015","unstructured":"Leuthold LA, Heudi O, Deglon J, Raccuglia M, Augsburger M, Picard F, et al. New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis. Anal Chem. 2015;87(4):2068\u201371.","journal-title":"Anal Chem"},{"key":"866_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.aca.2015.04.056","volume":"881","author":"PM Kesel De","year":"2015","unstructured":"De Kesel PM, Lambert WE, Stove CP. Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study. Anal Chim Acta. 2015;881:65\u201373.","journal-title":"Anal Chim Acta"},{"issue":"16","key":"866_CR24","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","volume":"86","author":"P Denniff","year":"2014","unstructured":"Denniff P, Spooner N. Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal Chem. 2014;86(16):8489\u201395.","journal-title":"Anal Chem"},{"issue":"3","key":"866_CR25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1515\/cclm-2016-0411","volume":"55","author":"N Verougstraete","year":"2017","unstructured":"Verougstraete N, Lapauw B, Van Aken S, Delanghe J, Stove C, Stove V. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patients. Clin Chem Lab Med. 2017;55(3):462\u20139.","journal-title":"Clin Chem Lab Med"},{"key":"866_CR26","doi-asserted-by":"crossref","unstructured":"Kok MGM, Fillet M. Volumetric absorptive microsampling: current advances and applications. J Pharm Biomed Anal. 2018;147:288\u201396.","DOI":"10.1016\/j.jpba.2017.07.029"},{"key":"866_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12887-016-0575-0","volume":"16","author":"R Atugonza","year":"2016","unstructured":"Atugonza R, Kakooza-Mwesige A, Lhatoo S, Kaddumukasa M, Mugenyi L, Sajatovic M, et al. Multiple anti-epileptic drug use in children with epilepsy in Mulago hospital, Uganda: a cross sectional study. BMC Pediatr. 2016;16:34.","journal-title":"BMC Pediatr"},{"issue":"Suppl 1","key":"866_CR28","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1046\/j.1365-2125.2001.00088.x","volume":"52","author":"NJ Gogtay","year":"2001","unstructured":"Gogtay NJ, Kshirsagar NA, Dalvi SS. Therapeutic drug monitoring in a developing country: an overview. Br J Clin Pharmacol. 2001;52(Suppl 1):103S\u20138S.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"866_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2165\/00003088-197803020-00003","volume":"3","author":"L Bertilsson","year":"1978","unstructured":"Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet. 1978;3(2):128\u201343.","journal-title":"Clin Pharmacokinet"},{"key":"866_CR30","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Center for Veterinary Medicine. Draft Guidance for Industry. Bioanalytical Method Validation. 2013. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm368107.pdf . Accessed June 2017."},{"key":"866_CR31","unstructured":"European Medicines Agency. Guideline on Bioanalytical Method Validation. 2015. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf . Accessed June 2017."},{"key":"866_CR32","doi-asserted-by":"crossref","unstructured":"Wille SMR, Peters FT, Di Fazio V, Samyn N. Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods. Accred Qual Assur. 2011;16(6):279\u201392.","DOI":"10.1007\/s00769-011-0775-0"},{"issue":"9","key":"866_CR33","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1021\/acs.analchem.5b00908","volume":"87","author":"P Abu-Rabie","year":"2015","unstructured":"Abu-Rabie P, Denniff P, Spooner N, Chowdhry BZ, Pullen FS. Investigation of different approaches to incorporating internal standard in DBS quantitative bioanalytical workflows and their effect on nullifying hematocrit-based assay bias. Anal Chem. 2015;87(9):4996\u20135003.","journal-title":"Anal Chem"},{"key":"866_CR34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-1-349-11234-0_20","volume-title":"Principles and practice of immunoassay","author":"T Houts","year":"1991","unstructured":"Houts T. Immunochromatography. In: Price CP, editor. Principles and practice of immunoassay. New York: Stockton Press; 1991. p. 563\u201383."},{"issue":"4","key":"866_CR35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/dta.1507","volume":"6","author":"T Launiainen","year":"2014","unstructured":"Launiainen T, Ojanpera I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6(4):308\u201316.","journal-title":"Drug Test Anal"},{"issue":"4","key":"866_CR36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00007691-198804000-00017","volume":"10","author":"RG Morris","year":"1988","unstructured":"Morris RG, Schapel GJ. Phenytoin and phenobarbital assayed by the ACCULEVEL method compared with EMIT in an outpatient clinic setting. Ther Drug Monit. 1988;10(4):469\u201373.","journal-title":"Ther Drug Monit"},{"issue":"7\u20138","key":"866_CR37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clinbiochem.2016.12.008","volume":"50","author":"C Linder","year":"2017","unstructured":"Linder C, Wide K, Walander M, Beck O, Gustafsson LL, Pohanka A. Comparison between dried blood spot and plasma sampling for therapeutic drug monitoring of antiepileptic drugs in children with epilepsy: a step towards home sampling. Clin Biochem. 2017;50(7\u20138):418\u201324.","journal-title":"Clin Biochem"},{"issue":"9","key":"866_CR38","doi-asserted-by":"crossref","first-page":"e108190","DOI":"10.1371\/journal.pone.0108190","volume":"9","author":"ST Kong","year":"2014","unstructured":"Kong ST, Lim SH, Lee WB, Kumar PK, Wang HY, Ng YL, et al. Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy. PLoS One. 2014;9(9):e108190.","journal-title":"PLoS One"},{"key":"866_CR39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpba.2014.03.044","volume":"96","author":"L Rhoden","year":"2014","unstructured":"Rhoden L, Antunes MV, Hidalgo P, Alvares da Silva C, Linden R. Simple procedure for determination of valproic acid in dried blood spots by gas chromatography-mass spectrometry. J Pharm Biomed Anal. 2014;96:207\u201312.","journal-title":"J Pharm Biomed Anal"}],"updated-by":[{"DOI":"10.1007\/s00216-018-0951-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000}}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-0866-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-0866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-0866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T17:39:41Z","timestamp":1719769181000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-0866-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-0866-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00216-018-0951-8","asserted-by":"object"}]},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]}}}